Malcolm R. Law
#142,642
Most Influential Person Now
Malcolm R. Law's AcademicInfluence.com Rankings
Malcolm R. Lawmedical Degrees
Medical
#2611
World Rank
#3042
Historical Rank
Cardiology
#241
World Rank
#247
Historical Rank
Epidemiology
#483
World Rank
#505
Historical Rank
Malcolm R. Lawphilosophy Degrees
Philosophy
#7506
World Rank
#10729
Historical Rank
Logic
#4556
World Rank
#5866
Historical Rank
Download Badge
Medical Philosophy
Malcolm R. Law's Degrees
- PhD Epidemiology University of California, Berkeley
- Doctorate Medicine Stanford University
Why Is Malcolm R. Law Influential?
(Suggest an Edit or Addition)Malcolm R. Law's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies (2009) (2510)
- Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis (2002) (1983)
- Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis (2003) (1769)
- A strategy to reduce cardiovascular disease by more than 80% (2003) (1583)
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? (1994) (1297)
- Interpretation of the evidence for the efficacy and safety of statin therapy (2016) (1290)
- Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials (2003) (1093)
- Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. (2003) (978)
- Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. (2009) (798)
- Statin safety: a systematic review. (2006) (757)
- The accumulated evidence on lung cancer and environmental tobacco smoke (1997) (742)
- Plant sterol and stanol margarines and health (2000) (731)
- A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect (1997) (683)
- Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence (1997) (629)
- By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction. (1991) (536)
- An analysis of the effectiveness of interventions intended to help people stop smoking. (1995) (468)
- Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. (2005) (427)
- Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. (1998) (385)
- By how much does dietary salt reduction lower blood pressure? I--Analysis of observational data among populations. (1991) (383)
- Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: data from the BUPA study (1994) (348)
- Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden (2006) (322)
- Assessing possible hazards of reducing serum cholesterol (1994) (321)
- Environmental tobacco smoke. (2008) (281)
- Risk factor thresholds: their existence under scrutiny (2002) (267)
- Strategies for prevention of osteoporosis and hip fracture. (1991) (261)
- By how much does dietary salt reduction lower blood pressure? I--Analysis of observational data among populations. (1991) (249)
- Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence (2006) (213)
- The underlying risk of death after myocardial infarction in the absence of treatment. (2002) (187)
- Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. (2006) (186)
- Why heart disease mortality is low in France: the time lag explanation. (1999) (185)
- Environmental tobacco smoke and ischemic heart disease. (2003) (169)
- Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study (1997) (166)
- Blood pressure and the global burden of disease 2000. Part 1: Estimates of blood pressure levels (2006) (154)
- Screening for osteoporosis (1992) (134)
- Dietary fat and adult diseases and the implications for childhood nutrition: an epidemiologic approach. (2000) (124)
- The dose-response relationship between cigarette consumption, biochemical markers and risk of lung cancer. (1997) (109)
- Serum cholesterol and ischaemic heart disease. (1995) (103)
- Changes in atopy over a quarter of a century, based on cross sectional data at three time periods (2005) (103)
- Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study (2000) (88)
- Genetic predisposition to lung cancer. (1990) (85)
- An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990. (1994) (83)
- Blood pressure and the global burden of disease 2000. Part II: Estimates of attributable burden. Commentary (2006) (80)
- Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies (1991) (79)
- By how much does dietary salt reduction lower blood pressure? II--Analysis of observational data within populations. (1991) (78)
- Lowering heart disease risk with cholesterol reduction : evidence from observational studies and clinical trials (1999) (71)
- Cigarette smoking, sex hormones and bone density in women (1997) (70)
- Headaches and the Treatment of Blood Pressure: Results From a Meta-Analysis of 94 Randomized Placebo-Controlled Trials With 24 000 Participants (2005) (67)
- Hospital-acquired infection with methicillin-resistant and methicillin-sensitive staphylococci (1988) (66)
- The Performance of Blood Pressure and other Cardiovascular Risk Factors as Screening Tests for Ischaemic Heart Disease and Stroke (2004) (54)
- Plant sterol and stanol margarines and health. (2000) (54)
- Serum albumin and mortality in the BUPA study. British United Provident Association. (1994) (51)
- The prevention of neonatal group B streptococcal disease: a report by a working group of the Medical Screening Society (2005) (49)
- The dose-response relation between serum homocysteine and cardiovascular disease: implications for treatment and screening (2004) (47)
- Epidemiologic evidence on salt and blood pressure. (1997) (47)
- Screening without evidence of efficacy (2004) (44)
- Salt, Blood Pressure and Cardiovascular Diseases (2000) (40)
- Folic acid food fortification to prevent neural tube defects (1998) (39)
- Screening for Abdominal Aortic Aneurysms (1994) (34)
- Use of personal medical records for research purposes (1994) (33)
- The importance of age in screening for cancer (1999) (32)
- IS ROUTINE VITAMIN E ADMINISTRATION JUSTIFIED IN VERY LOW‐BIRTHWEIGHT INFANTS? (1990) (30)
- Methicillin-resistant Staphylococcus aureus: associated morbidity and effectivencess of control measures (1988) (27)
- Serum triglyceride: a possible risk factor for ruptured abdominal aortic aneurysm. (1998) (26)
- The Indian Polycap Study (TIPS) (2009) (25)
- An Appraisal of the Efficacy and Cost Effectiveness of Antenatal Screening for Hepatitis B (1997) (24)
- Commentary: Having too much evidence (depression, suicide, and low serum cholesterol) (1996) (24)
- Homocysteine and ischaemic heart disease. (1999) (21)
- Dietary salt and blood pressure. (1991) (20)
- Contact tracing and population screening for tuberculosis--who should be assessed? (2003) (19)
- A randomized double-blind crossover trial to investigate the efficacy of screening for adult hypothyroidism (2010) (18)
- Commentary: Evidence on salt is consistent (1996) (17)
- Value of low dose combination treatment with blood pressure lowering drugs (2014) (15)
- Lipids and Cardiovascular Disease (2007) (14)
- Labetalol and priapism. (1980) (13)
- Dietary salt and blood pressure (1994) (12)
- Efficacy and safety of cholesterol-lowering treatment (2006) (12)
- Serum cholesterol and cancer. (1992) (12)
- Serum homocysteine and the severity of coronary artery disease. (2003) (12)
- Fortifying food with folic acid. (2000) (12)
- What Now on Screening for Prostate Cancer? (2009) (10)
- Folic acid fortification in the prevention of neural tube defects. (2004) (10)
- Mortality from hypertrophic cardiomyopathy in England and Wales: clinical and screening implications. (2004) (10)
- A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction. (2008) (9)
- Calcium channel blockers and headache. (2007) (9)
- Breast screening saves lives (2009) (9)
- Screening for abdominal aortic aneurysms. (1994) (8)
- Vitamin B-12 and folate deficiency in elderly persons. (2004) (8)
- Proceedings from the workshop on estimating the contributions of sodium reduction to preventable death (2011) (8)
- Apolipoproteins and prediction of fatal myocardial infarction (2002) (6)
- Adipose tissue trans fatty acids and coronary heart disease (1995) (6)
- “Polypill” to fight cardiovascular disease: Authors' reply (2003) (6)
- Attribution of time lag theory to explain French paradox (1999) (6)
- Lipids and cholesterol (2005) (5)
- Commentary: Disagreements are not substantial (1994) (5)
- Statins for people at low risk of cardiovascular disease (2012) (5)
- The threat to the use of records and stored blood samples in medical screening research (2001) (5)
- The sick building syndrome (1985) (4)
- Screening for future coronary heart disease (2005) (4)
- MRC/BHF Heart Protection Study (2002) (4)
- Salt and blood pressure (1995) (4)
- "Opportunistic" screening. (1994) (3)
- evidence on causality from a meta-analysis Homocysteine and cardiovascular disease: (2005) (3)
- Formulation for Cardiovascular Disease Prevention (2001) (3)
- Preventing oesteoporosis: Authors' reply (1991) (3)
- Folate and risk of cardiovascular disease (2003) (3)
- The Global Commission on Women's Health. (1994) (2)
- Dietary salt and blood pressure. (1994) (2)
- The serum folate response to the US mandatory fortification of grain products with folic acid. (2002) (2)
- Lipid lowering may reduce major cardiovascular events, regardless of pre-treatment cholesterol levels. (2006) (2)
- Serum cholesterol concentrations in parasuicide (1995) (2)
- Hypertrophic cardiomyopathy: Sudden death is rare in young people with hypertrophic cardiomyopathy (2006) (2)
- A change in paradigm: Lowering blood pressure in everyone over a certain age (2012) (2)
- Sodium and cardiovascular disease (2016) (2)
- Post-operative intrapleural BCG in lung cancer. (1988) (2)
- The Health Service and Personal Costs of Screening (1995) (2)
- Postmenopausal osteoporosis—who is at risk and how do we identify them? (1993) (2)
- MRC/BHF Heart protection study. Authors' reply (2002) (1)
- Misleading meta-analysis (1995) (1)
- Salt, diet & health: Neptune's poisoned chalice: the origins of high blood pressure. (1999) (1)
- Screening mammography re-evaluated (2000) (1)
- How frequently should cervical screening be conducted – important new evidence (2003) (1)
- Long term effects of advice to reduce dietary salt. Salt needs to be reduced in manufacturing and processing food. (2003) (1)
- Apolipoproteins and prediction of fatal myocardial infarction. Authors' reply (2002) (1)
- Clinical Consequences of Lowering Cholesterol (1996) (1)
- Lowering cholesterol concentrations and mortality (1990) (1)
- Dietary fat and adult diseases and the implications for childhood nutrition: an epidemiologic approach 1–3 (2000) (0)
- Ischaemic heart disease and cholesterol: Author's reply (1994) (0)
- Cochrane report on lowering blood pressure (2014) (0)
- Response to Hooper et al (2017) (0)
- Oral potassium reduced systolic and diastolic BP in hypertensive and normotensive participants. (1997) (0)
- Folate and risk of cardiovascular disease. Authors' reply (2003) (0)
- Antenatal screening for hepatitis B - Reply (1998) (0)
- Randomized clinical trials: design, practice and reporting (2010) (0)
- Oxford Textbook of Public Health (1985) (0)
- Atorvastatin prevented early recurrence of ischemic events and death in patients with unstable angina or non-Q-wave MI: Lipid-lowering drugs prescription of lipid-lowering drugs at hospital discharge following an acute coronary syndrome was associated with reduced short-term mortality (2001) (0)
- Screening for osteopororis. Author's replyl (1992) (0)
- Adipose tissue trans fatty acids and coronary heart disease. (1995) (0)
- The GP's role in sexual medicine. (1976) (0)
- Book Review: History of Cervical Cancer and the Role of Human Papillomavirus, 1960-2000 (2010) (0)
- The vagaries of prostate cancer screening (2004) (0)
- Plasma LDL concentrations achieved by pravastatin reduced coronary event rate. (1998) (0)
- Law more than 80 % A strategy to reduce cardiovascular disease (2003) (0)
- Brief Communication Serum homocysteine and the severity of coronary artery disease (2003) (0)
- Formulation destinee a la prevention de maladies cardio-vasculaires (2001) (0)
- Inborn Susceptibility/Resistance to Lung Cancer (1982) (0)
- Cholesterol and all-cause mortality in Honolulu (2001) (0)
- Blood pressure meta-analysis highlights an implementation gap (2022) (0)
- Response to Gotzsche (2018) (0)
- Medical screening (2020) (0)
- Book Review: Towards a Screening Strategy for Scotland. Report of a Forum Working Group on Screening, August 1994 (1995) (0)
- Serumcholesterol andsubsequent riskofcancer:results fromthe BUPA study (1989) (0)
- Reducing the Risk of Cancers (1994) (0)
- Polypill in Persons without Cardiovascular Disease. (2021) (0)
- Authors’ reply (2009) (0)
- Annual Review of Public Health Vol 9, 1988 (1989) (0)
- Risk factor thresholds. Author's reply (2002) (0)
- Blood pressure-lowering treatment should be based on the level of cardiovascular risk, not on the level of blood pressure (2014) (0)
- Bmj Lung Cancer and Passive Smoking (2015) (0)
- Rudnicka meta-analysis disease , and stroke : systematic review and lipoprotein cholesterol , ischaemic heart Quantifying effect of statins on low density (2003) (0)
- Cholesterol, statins, and mortality (2008) (0)
- Does Smoking have any Influence on the Course of Restrictive Lung Disease (1984) (0)
- Psychological determinants of metabolic risk (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Malcolm R. Law?
Malcolm R. Law is affiliated with the following schools:
